Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression

NCT00622245 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

166

Enrollment

INDUSTRY

Sponsor class

Stopped Human metabolite not yet covered sufficiently by nonclinical data

Conditions

Depression in Patients With Bipolar Disorder

Interventions

DRUG: Lu AA34893
DRUG: Quetiapine fumarate
DRUG: Placebo

Sponsor

H. Lundbeck A/S